pubmed-article:21489413 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C0039194 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C1167250 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C0023690 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C1819364 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C0108779 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C1332709 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C0332196 | lld:lifeskim |
pubmed-article:21489413 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
pubmed-article:21489413 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:21489413 | pubmed:dateCreated | 2011-7-4 | lld:pubmed |
pubmed-article:21489413 | pubmed:abstractText | The antibody 13B8.2, which is directed against the CDR3-like loop on the D1 domain of CD4, induces CD4/ZAP-70 reorganization and ceramide release in membrane rafts. Here, we investigated whether CD4/ZAP-70 compartmentalization could be mediated by an effect of 13B8.2 on the Carma1-Bcl10-MALT1 complex in membrane rafts. We report that treatment of CD3/CD28-activated Jurkat T cells with 13B8.2, but not rituximab, excluded Carma1-Bcl10-MALT1 proteins from GM1(+) membrane rafts and concomitantly decreased NF-?B activation. Fluorescence confocal imaging confirmed that Carma1-Bcl10 and Carma1-MALT1 co-patching, observed in GM1(+) membrane rafts following CD3/CD28 activation, were abrogated after a 24h-treatment with 13B8.2. The CD4/ZAP-70 compartmentalization in membrane rafts induced by 13B8.2 is thus related to Carma1-Bcl10-MALT1 raft exclusion. | lld:pubmed |
pubmed-article:21489413 | pubmed:language | eng | lld:pubmed |
pubmed-article:21489413 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21489413 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21489413 | pubmed:issn | 1090-2163 | lld:pubmed |
pubmed-article:21489413 | pubmed:author | pubmed-author:ChardèsThierr... | lld:pubmed |
pubmed-article:21489413 | pubmed:author | pubmed-author:PèlegrinAndré... | lld:pubmed |
pubmed-article:21489413 | pubmed:author | pubmed-author:ChentoufMyria... | lld:pubmed |
pubmed-article:21489413 | pubmed:author | pubmed-author:RigoMaximeM | lld:pubmed |
pubmed-article:21489413 | pubmed:copyrightInfo | Copyright © 2011 Elsevier Inc. All rights reserved. | lld:pubmed |
pubmed-article:21489413 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21489413 | pubmed:volume | 270 | lld:pubmed |
pubmed-article:21489413 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21489413 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21489413 | pubmed:pagination | 40-6 | lld:pubmed |
pubmed-article:21489413 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:meshHeading | pubmed-meshheading:21489413... | lld:pubmed |
pubmed-article:21489413 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21489413 | pubmed:articleTitle | CD4 ligation excludes the Carma1-Bcl10-MALT1 complex from GM1-positive membrane rafts in CD3/CD28 activated T cells. | lld:pubmed |
pubmed-article:21489413 | pubmed:affiliation | IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier F-34298, France. | lld:pubmed |
pubmed-article:21489413 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21489413 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |